BRIEF-CytomX Therapeutics Inc expects 2016 net cash utilization of $20 mln-$25 mln

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.